Advanced search×

Efficient synthesis of AMP579, a novel adenosine A1/A2 receptor agonist.

J Org Chem 65(23):8114-8 (2000) PMID 11073633

Version: za2963e q8za4 q8zba q8zcf q8zdb q8ze0 q8zfe q8zga

Similar articles you may find interesting…

  1. Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?

    Metab Brain Dis (2013) PMID 23653255

    We describe the clinical and molecular relationship between obesity and neurodegenerative disease. Secondly we outline the protective role of weight loss, metabolic and caloric modifying interventions in the context of AD and PD. We conclude that the application of caloric restriction through dietar...
  2. Synthesis of Uniform CdS Nanospheres/Graphene Hybrid Nanocomposites and Their Application as Visible Light Photocatalyst for Selective Reduc...

    ACS Appl Mater Interfaces (2013) PMID 23646877

    We report the self-assembly of uniform CdS nanospheres/graphene (CdS NSPs/GR) hybrid nanocomposites via electrostatic interaction of positively charged CdS nanospheres (CdS NSPs) with negatively charged graphene oxide (GO), followed by GO reduction via a hydrothermal treatment. During this facile tw...
  3. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small Mole...

    Drug Metab Dispos (2013) PMID 23653442

    4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP) represents a novel small molecule activator of the glucagon-like peptide-1 receptor (GLP-1R), and exhibits glucose-dependent insulin secretion in rats following intravenous (but not oral) administration. I...